{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:25:08Z","timestamp":1785450308712,"version":"3.56.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,28]]},"abstract":"<jats:p>Studies of travellers returning from Africa with uncomplicated Plasmodium falciparum infection are starting to provide signals of failure of artemether-lumefantrine, a first-line treatment of uncomplicated malaria. Traveller-based reports offer an important adjunct to antimalarial efficacy studies performed in endemic regions.<\/jats:p>","DOI":"10.1093\/jtm\/taad159","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T10:30:49Z","timestamp":1702722649000},"source":"Crossref","is-referenced-by-count":14,"title":["Out of Africa: Increasing reports of artemether-lumefantrine treatment failures of uncomplicated <i>Plasmodium falciparum<\/i> infection"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6291-8923","authenticated-orcid":false,"given":"Eric S","family":"Halsey","sequence":"first","affiliation":[{"name":"Travelers\u2019 Health Branch, Centers for Disease Control and Prevention Division of Global Migration Health, , Atlanta 30329-4027, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz M","family":"Plucinski","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention Division of Parasitic Diseases and Malaria, Malaria Branch, , Atlanta 30329-4027, USA"},{"name":"Centers for Disease Control and Prevention U.S. President\u2019s Malaria Initiative, , Atlanta 30329-4027, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"2023122813305980000_ref1","volume-title":"Strategy to Respond to Antimalarial Drug Resistance in Africa","author":"World Health Organization","year":"2022"},{"key":"2023122813305980000_ref2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(79)92383-3","article-title":"Chloroquine-resistant Plasmodium falciparum from East Africa","volume":"314","author":"Campbell","year":"1979","journal-title":"Lancet"},{"key":"2023122813305980000_ref3","doi-asserted-by":"crossref","first-page":"taad114","DOI":"10.1093\/jtm\/taad114","article-title":"Emergence of artemisinin-based combination treatment failure in patients returning from sub-Saharan Africa with P. falciparum malaria","author":"Grossman","year":"2023","journal-title":"J Travel Med"},{"key":"2023122813305980000_ref4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12936-021-03585-6","article-title":"Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017\u20132018","volume":"20","author":"Gansan\u00e9","year":"2021","journal-title":"Malar J"},{"key":"2023122813305980000_ref5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4269\/ajtmh.21-0214","article-title":"Therapeutic efficacy of artemisinin-based combination therapies in Democratic Republic of the Congo and investigation of molecular markers of antimalarial resistance","volume":"105","author":"Moriarty","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"2023122813305980000_ref6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12936-021-04021-5","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda","volume":"20","author":"Ebong","year":"2021","journal-title":"Malar J"},{"key":"2023122813305980000_ref7","article-title":"Treatment failure in a UK malaria patient harbouring genetically variant Plasmodium falciparum from Uganda with reduced in vitro susceptibility to artemisinin and lumefantrine","author":"Schalkwyk","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2023122813305980000_ref8","doi-asserted-by":"crossref","first-page":"101505","DOI":"10.1016\/j.tmaid.2019.101505","article-title":"Imported malaria and artemisinin-based combination therapy failure in travellers returning to Belgium: a retrospective study","volume":"32","author":"Rovira-Vallbona","year":"2019","journal-title":"Travel Med Infect Dis"},{"key":"2023122813305980000_ref9","doi-asserted-by":"crossref","first-page":"taz082","DOI":"10.1093\/jtm\/taz082","article-title":"Plasmodium falciparum malaria recrudescence after treatment with artemether\u2013lumefantrine","volume":"27","author":"Bourque","year":"2020","journal-title":"J Travel Med"},{"key":"2023122813305980000_ref10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/cid\/ciw710","article-title":"High rate of treatment failures in nonimmune travelers treated with Artemether-Lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden: retrospective comparative analysis of effectiveness and case series","volume":"64","author":"Sond\u00e9n","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2023122813305980000_ref11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/432554","article-title":"Coartem (artemether-lumefantrine) in Africa: the beginning of the end?","volume":"192","author":"Hastings","year":"2005","journal-title":"J Infect Dis"},{"key":"2023122813305980000_ref12","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","article-title":"Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda","volume":"13","author":"Tumwebaze","year":"2022","journal-title":"Nat Commun"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taad159\/54586462\/taad159.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/30\/8\/taad159\/54913850\/taad159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/30\/8\/taad159\/54913850\/taad159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T13:31:09Z","timestamp":1703770269000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taad159\/7477808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":12,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12,18]]},"published-print":{"date-parts":[[2023,12,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taad159","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,12]]},"article-number":"taad159"}}